Top Upgrades
- Analysts at Bank of America upgraded Zynga Inc ZNGA from Underperform to Neutral. Zynga shares rose 11.27 percent to $3.16 in pre-market trading.
- Analysts at Cantor Fitzgerald upgraded Web.com Group Inc WEB from Hold to Overweight. Web.com shares dropped 0.51 percent to $19.50 in after-hours trading.
- Analysts at Wells Fargo upgraded Hess Corp. HES from Market Perform to Outperform. Hess shares fell 2.20 percent to close at $45.84 on Thursday.
- Guggenheim upgraded IAC/InterActiveCorp IAC from Neutral to Buy. IAC/InterActive shares climbed 1.64 percent to $99.40 in pre-market trading.
- Macquarie upgraded Verisk Analytics, Inc. VRSK from Neutral to Outperform. Verisk Analytics shares rose 0.50 percent to $78.40 in pre-market trading.
- Raymond James upgraded Targa Resources Corp TRGP from Outperform to Strong Buy. Targa Resources shares rose 0.49 percent to $49.15 in pre-market trading.
- Canaccord Genuity upgraded Regeneron Pharmaceuticals Inc REGN from Hold to Buy. Regeneron Pharmaceuticals shares rose 0.85 percent to $438.00 in pre-market trading.
- Analysts at UBS upgraded CF Industries Holdings, Inc. CF from Neutral to Buy. CF Industries shares rose 0.66 percent to $27.25 in pre-market trading.
- Oppenheimer upgraded Regal Beloit Corp RBC from Perform to Outperform. Regal Beloit shares gained 0.06 percent to close at $78.75 on Thursday.
- JP Morgan upgraded Scripps Networks Interactive, Inc. SNI from Neutral to Overweight. Scripps Networks shares rose 2.63 percent to close at $70.20 on Thursday.
Top Downgrades
- Wells Fargo downgraded U.S. Bancorp USB from Outperform to Market Perform. US Bancorp shares rose 0.19 percent to close at $52.31 on Thursday.
- Baird downgraded Akamai Technologies, Inc. AKAM from Outperform to Neutral. Akamai Technologies shares fell 0.28 percent to $52.71 in pre-market trading.
- Goldman Sachs downgraded Yum China Holdings Inc YUMC from Buy to Neutral. Yum China shares dropped 1.65 percent to close at $34.50 on Thursday.
- Analysts at FBR Capital downgraded National CineMedia, Inc. NCMI from Outperform to Market Perform. National CineMedia shares dropped 1.51 percent to close at $11.72 on Thursday.
- Jefferies downgraded MAXIMUS, Inc. MMS from Buy to Hold. Maximus shares gained 2.85 percent to close at $61.39 on Thursday.
- JMP Securities downgraded Kennedy-Wilson Holdings Inc KW from Market Outperform to Market Perform. Kennedy-Wilson shares gained 0.74 percent to close at $20.40 on Thursday.
- Societe Generale downgraded Estee Lauder Companies Inc EL from Buy to Hold. Estee Lauder shares rose 0.61 percent to close at $91.86 on Thursday.
- Analysts at Baird downgraded Stericycle Inc SRCL from Neutral to Underperform. Stericycle shares rose 1.28 percent to $86.83 in pre-market trading.
- Argus Research downgraded Celgene Corporation CELG from Buy to Hold. Celgene shares fell 0.48 percent to $123.86 in pre-market trading.
- Morgan Stanley downgraded Choice Hotels International Inc CHH from Overweight to Equal-Weight. Choice Hotels shares gained 1.85 percent to close at $66.10 on Thursday.
Top Initiations
- Analysts at BMO Capital initiated coverage of Coherus Biosciences Inc CHRS with an Outperform rating. The price target for Coherus Biosciences is set to $54. Coherus Biosciences shares closed at $19.30 on Thursday.
- Analysts at UBS initiated coverage on Alder Biopharmaceuticals Inc ALDR with a Sell rating. The price target for Alder Biopharmaceuticals is set to $13. Alder Biopharmaceuticals shares closed at $21.80 on Thursday.
- Analysts at Cantor Fitzgerald initiated coverage on Versartis Inc VSAR with an Overweight rating. The price target for Versartis is set to $34. Versartis shares closed at $17.05 on Thursday.
- Analysts at Bank of America initiated coverage on Neurocrine Biosciences, Inc. NBIX with a Buy rating. The price target for Neurocrine Biosciences is set to $70. Neurocrine Biosciences shares closed at $53.63 on Thursday.
- Analysts at Citi initiated coverage on Playa Hotels & Resorts NV PLYA with a Neutral rating. Playa Hotels shares closed at $10.16 on Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: UpgradesDowngradesInitiationAnalyst RatingsBiotechnologyDowngradesHealth CareInitiationstop upgrades
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in